VIVOS THERAPEUTICS, INC. (VVOS) Gross margin 2019–2025
VIVOS THERAPEUTICS, INC. (VVOS) gross margin by fiscal year — reported gross profit divided by reported revenue.
60.4%FY2025 · since FY2019: 76.0% → 60.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 60.4% | +0.4 pp |
| FY2024 | 60.0% | +0.1 pp |
| FY2023 | 59.9% | -2.6 pp |
| FY2022 | 62.5% | -12.1 pp |
| FY2021 | 74.6% | -5.0 pp |
| FY2020 | 79.7% | +3.7 pp |
| FY2019 | 76.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VVOS financial trends
VVOS RevenueVVOS Net incomeVVOS Net marginVVOS Gross profitVVOS Operating incomeVVOS Operating marginVVOS Operating cash flowVVOS Free cash flowVVOS Capital expendituresVVOS Return on equityVVOS Stock buybacksVVOS Dividends paidVVOS Total assetsVVOS Total liabilitiesVVOS Shareholders’ equityVVOS overview →